Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 09, 2024
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Journal: The oncologist
Published: June 13, 2018
Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
Journal: American journal of surgery
Published: February 16, 2018
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 12, 2017
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Journal: Clinical breast cancer
Published: February 27, 2016
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2015
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 21, 2014
Weight loss interventions for breast cancer survivors: impact of dietary pattern.
Journal: PloS one
Published: July 11, 2014
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: September 07, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026